Multiomics Market Size

Request Free Sample Copy

Report ID: 6091
Published Date: Sep 17, 2025
Report Format: PDF, PPT

Buy Now

Multiomics Market Outlook:

Multiomics Market size was valued at USD 2.81 billion in 2025 and is expected to reach USD 11.67 billion by 2035, expanding at around 15.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of multiomics is evaluated at USD 3.2 billion.

The multiomics market's growth is accelerated by the growing need for targeted medicines and personalized medicine. Together, all of the previously listed elements support the market's growth. The predicted response for genome-targeted therapy by European Society for Medical Oncology was 2.73% in 2006, rose to 5.48% by the end of 2018, and has now risen to 7.04% in 2020. The anticipated response for genome-informed therapy was 3.33% in 2006, 7.68% in 2018, and 11.10% in 2020.

Browse key industry insights with market data tables & charts from the report:

Multiomics Market Size, Share, Trends & Growth Report 2035

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of multiomics is evaluated at USD 3.2 billion.

The global multiomics market size exceeded USD 2.81 billion in 2025 and is set to expand at a CAGR of over 15.3%, surpassing USD 11.67 billion revenue by 2035.

North America multiomics market will hold more than 40% share by 2035, attributed to the presence of important players and increased business efforts to expand visibility in the market.

Key players in the market include Thermo Fisher Scientific, Inc., Illumina, Inc., Danaher Corporation, PerkinElmer, Inc., Bruker, Centogene N.V., Element Biosciences, QIAGEN, Agilent Technologies, Inc.